the curren t status of the Im plex nCA LZ 300 I totally implantable hearing aid .
The first implants in human s were performed in 1998, and the sys tem was approved fo r routine use in Europe in October 1999. Th e device is com pletely imp lanted. The system is simi lar to that developed by Suzuki and Ya nagi hara and colleagues in Ja pa n. It involves a her metica lly sealed conventional mic rophone, battery, electronic unit, and piezoelec tric vibra tor of the oss icular cha in. Th e major advance that made this sys tem possible was the perfection of a battery that could be safely impl anted. It is likely that all patients who wis h to have their hearing restored to norm al without the use of a conventional hearing aid, and who can afford to do so, will obtai n totally imp lanted hearing aids .
Th e surge ry required to impl ant the device ca n be performed under local OI' genera l anes thesia in an outpatient setti ng. Th is procedure confers far less risk of postoperative vertigo and sensori neural hear ing loss than does stape dec tomy. The battery life of this prosthes is is acce ptable, and it will no doubt increase sig nificantly with advanced techn ology in the future. Th e sa me totally implantable micropho nes and batteries will also be used soo n for coc hlear implant s, whic h will make them totall y impl antable as weIl.
We have entere d a new and exci ting phase in oto logy that will re ma in prom inent until hearing loss can be prevented and lost hear ing ca n be restore d by advances in ge ne engineering and molecular biology. 
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